Hyponatremia and MAP-kinase inhibitors in malignant melanoma: Frequency, pathophysiological aspects and clinical consequences. Assan, Florence; Vilaine, Eve; Wagner, Sandra; Longvert, Christine; Saiag, Philippe; Seidowsky, Alexandre; Bourgault-Villada, Isabelle; Massy, Ziad A.. Pigment Cell & Melanoma Research. 2019; 32: p.326-331. doi:10.1111/pcmr.12749Article
Épidémiologie clinique